Avalon SteriTech develops cleaning, disinfection and sterilization technology infrastructure for public spaces. The company is part of the Avalon Group, a Hong Kong biomedical group founded in 2013, and is led by CEO Lewis Ho. Avalon plans to use newly raised funds to expedite overseas expansion, with a focus on the Asia Pacific and Middle East markets. It also intends to advance product development by building robotics, biotech, AI and data science capabilities. Avalon has entered the Hong Kong Science & Technology Parks Corporation (HKSTP) Elite Program and is eligible to receive up to HK$21.5 million to support growth. The company aspires to become a worldwide leader in public health infrastructure and protection.

Total raised

$9M

Funding rounds

1

Latest round

Series A

Latest activity

Dec 2022